# De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

> **NCT05213676** · PHASE4 · RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 600 (estimated)

## Conditions studied

- Congenital Diaphragmatic Hernia

## Interventions

- **DRUG:** Inhaled Nitric Oxide (iNO) use
- **OTHER:** De-implementation of Inhaled Nitric Oxide (iNO) use

## Key facts

- **NCT ID:** NCT05213676
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2030-10-31
- **Final completion:** 2031-04-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05213676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05213676, "De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05213676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*